News

Biostock studiointervju: AcuCort ger uppdateringar om marknadsansökan

4 mars, 2020

See presentation here (in Swedish) [Läs mer]

AcuCort company presentation at BioStock Live February 13th

3 mars, 2020

See presentation here [Läs mer]

AcuCort confirms response from the Swedish MPA regarding ISICORT® market application

13 februari, 2020

AcuCort AB (Spotlight Stock Market: ACUC) has received the Primary Round Assessment Report from the Swedish Medical Products... [Läs mer]

AcuCort’s CEO to present at BIO Europe Spring in Paris and BioStock Live in Stockholm

5 februari, 2020

The BIO Europe Spring conference is Europe’s largest springtime Biotech partnering event. In addition to partnering meetings, BIO... [Läs mer]

AcuCort reports positive outcome of the expert group work

20 januari, 2020

AcuCort AB (Spotlight Stock Market: ACUC) today reports a positive view, concluding that the outcome of the second... [Läs mer]

AcuCort strengthens its organization and appoints interim CEO

12 december, 2019

AcuCort AB (Spotlight Stock Market: ACUC) today announces that the company strengthens its organization and hires Ann Gidner... [Läs mer]

AcuCort: New patent granted in Europe

18 november, 2019

AcuCort AB (Spotlight Stock Market: ACUC) today announces that the European Patent Office (EPO) has approved the patent... [Läs mer]

AcuCort gives an update on the continued work concerning the bioequivalence study for US registration

8 november, 2019

AcuCort AB (Spotlight Stock Market: ACUC) gives further information on the results from the second bioequivalence study for... [Läs mer]

AcuCort reports that bioequivalence was not achieved in the second study for US registration

16 oktober, 2019

This is an English version of the press release published in Swedish on October 15, at 15:59 (SE... [Läs mer]

AcuCort applies for market approval of ISICORT^® in Sweden

30 september, 2019

AcuCort AB (Spotlight Stock Market: ACUC) announces that the company has submitted a national hybrid application for approval... [Läs mer]